Visterra Receives $12,906,300 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=24e708f2-f33f-49d6-8621-ad70cc5bb50d&Preview=1 -
Date
5/29/2012 -
Company Name
Visterra -
Mailing Address
One Kendall Square Cambridge, MA 02139 -
Company Description
Visterra, Inc. is dedicated to the discovery and development of innovative products for the prevention, treatment and diagnosis of infectious diseases. The Company focuses on technologies that can interrogate how pathogens interact with human cells, a critical first step in the disease process. The company’s lead programs are focused on seasonal and pandemic influenza. -
Website
http://www.visterrainc.com -
Transaction Type
Venture Equity -
Transaction Amount
$12,906,300 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
